113. Muscular dystrophy
567 clinical trials,   442 drugs   (DrugBank: 93 drugs),   55 drug target genes,   151 drug target pathways

Searched query = "Muscular dystrophy", "Dystrophinopathies", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "Rigid spine syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000016092
2014/12/3131/12/2014Analysis of the effects of animal fat free diet and aspirin for prostaglandins in patients with myotonic dystrophy myotonic dystrophy1st stage (1w): animal fat free diet
2nd stage (1w): animal fat free diet and aspirin (330mg/day)
National Hospital Organization Toneyama National HospitalGraduate school of engineering Osaka UniversityComplete: follow-up completeNot applicableNot applicableMale and Female10Not applicableJapan
2JPRN-UMIN000009307
2012/11/0810/11/2012Inhibition of prostagrandin synthesis for the treatment of Duchenne musclar dystrophy Duchenne muscular dystrophyoral adm,inistration of aspirinKobe University Graduate School of MedicineNULLComplete: follow-up complete5years-oldNot applicableMale6Phase 1;Phase 2Japan